Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets

August 18, 2026 3:49 PM

Brookline Capital Markets analyst Kemp Dolliver lowered the price target on Outlook Therapeutics Inc. (NASDAQ: OTLK) to $4.00 (from $6.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found